Results 41 to 50 of about 98,491 (346)

Comparison of interferon gamma release assay & tuberculin skin tests for diagnosis of latent tuberculosis in patients on maintenance haemodialysis

The Indian journal of medical research, 2015
Background & objectives: Tuberculosis (TB) is a common infection in patients on haemodialysis. There is a definite role of treatment of latent TB (LTB) in these patients.
S. Agarwal, U. Singh, Saba Zaidi, Sanjay Gupta, R. Pandey   +4 more
semanticscholar   +1 more source

Diagnostic performance of interferon‐gamma release assay for diagnosis of tuberculous pericarditis: A meta‐analysis

International journal of clinical practice, 2020
The diagnosis of tuberculous pericarditis is difficult to set, not only for its non‐specific clinical presentation, but also for the lack of useful diagnostic tests.
H. Seo, Yun-Seong Kim, H. Ock, Lae Hyung Kang, K. Byun, D. Jeon, Seong Jang Kim   +6 more
semanticscholar   +1 more source

Serial Interferon-Gamma Release Assay (IGRA) Testing to Monitor Treatment Responses in Cases of Feline Mycobacteriosis [PDF]

Pathogens, 2021
The interferon-gamma release assay (IGRA) is used to diagnose cases of feline mycobacteriosis, but the use of serial testing to monitor treatment responses has not been evaluated in this species. From a population of cats that underwent IGRA testing for diagnostic investigation, individuals were identified with a pre- and end-of-treatment IGRA that ...
Jordan L. Mitchell, Conor O’Halloran, Paul Stanley, Kieran McDonald, Paul Burr, Danièlle A. Gunn-Moore, Jayne C. Hope   +6 more
openaire   +4 more sources

T-SPOT. TB assay and tuberculin skin test for diagnosis and screening of tuberculosis: First report in a Sri lankan population

Asian Journal of Medical Sciences, 2015
Objective: Guidelines encourage evaluation of an Interferon Gamma Release Assay (IGRA) in the local setting, particularly in low/ middle income, Bacillus Calmette Guerin (BCG) vaccinated populations where the assays have shown variable utility. The TSPOT.
Champa N Ratnatunga
doaj   +1 more source

Role of QuantiFERON-TB gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis. [PDF]

PLoS ONE, 2010
The measurement of Interferon gamma or Interferon gamma inducible protein (IP)-10 in antigen stimulated blood samples is suggested as an alternative method for latent tuberculosis (TB) diagnosis.
Basirudeen Syed Ahamed Kabeer, Balambal Raman, Aleyamma Thomas, Venkatesan Perumal, Alamelu Raja   +4 more
doaj   +1 more source

Negative Effect of Smoking on the Performance of the QuantiFERON TB Gold in Tube Test. [PDF]

, 2012
False negative and indeterminate Interferon Gamma Release Assay (IGRA) results are a well documented problem. Cigarette smoking is known to increase the risk of tuberculosis (TB) and to impair Interferon-gamma (IFN-γ) responses to antigenic challenge ...
A Cattamanchi, Aase B Andersen, B Ramin, DA Lewinsohn, Daniel Faurholt-Jepsen, DI Ling, E Belard, E Bruzzese, G Baynam, George PrayGod, GH Mazurek, Henrik Friis, HH Lin, I Doyle, I Solovic, John Changalucha, JS Mackenzie, K Slama, Kidola Jeremiah, L Arcavi, M Hoffmann, M Ruhwald, M Sester, MA Modestou, Maria Faurholt-Jepsen, Martine G Aabye, MG Aabye, MG Aabye, MN Bates, Morten Ruhwald, NK Dhillon, Nyagosya Range, P Beffa, Pernille Ravn, PG Holt, PG Holt, R Diel, R Diel, RN van Zyl Smit, SJ Lee, Thomas Stig Hermansen, Y Feng, Y Kobashi, Y Ouyang   +43 more
core   +1 more source

Tuberculosis screening among HIV-infected patients: tuberculin skin test vs. interferon-gamma release assay [PDF]

AIDS Care, 2017
National guidelines recommend screening for latent tuberculosis infection (LTBI) in all HIV-infected patients. Thus, the objective of this study was to measure protocol adherence to national guidelines regarding LTBI screening for HIV-infected patients entering care at an urban primary care clinic specializing in HIV care, identify clinical and other ...
J. W. Adams, C. J. Howe, A. C. Andrews, S. L. Allen, C. Vinnard   +4 more
openaire   +2 more sources

Evaluation of a commercial interferon-γ release assay for the detection of SARS-CoV-2 T-cell response after vaccination

Heliyon, 2023
Objective: Evidence regarding the role of cellular immunity in protecting against COVID-19 is emerging. To better assess immune status, simple and robust assays measuring specific T-cell responses associated with humoral responses are needed. We aimed to
Imane Saad Albichr, Samy Mzougui, Arnaud Devresse, Hélène Georgery, Eric Goffin, Nada Kanaan, Jean Cyr Yombi, Leila Belkhir, Julien De Greef, Anaïs Scohy, Hector Rodriguez-Villalobos, Benoît Kabamba-Mukadi   +11 more
doaj   +1 more source

Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysis [PDF]

, 2016
UNLABELLED: Prisoners have a high prevalence of hepatitis C virus (HCV), but case-finding may not have been cost-effective because treatment often exceeded average prison stay combined with a lack of continuity of care. We assessed the cost-effectiveness
Brew, Iain F., Hickman, Mathew, Hutchinson, Sharon J., Irving, William L., Mandal, Sema, Martin, Natasha K., Miners, Alec, O'Moore, Eamonn, Saksena, Sushma, Vickerman, Peter, Williamson, Joan   +10 more
core   +3 more sources

Tuberculin skin test and interferon‐γ release assays: Can they agree?

The Clinical Respiratory Journal, 2023
Introduction The diagnosis of latent tuberculosis infection (LTBI) relies largely on the tuberculin skin test (TST) or, more recently, on interferon‐gamma release assays (IGRA).
João Almeida Santos, Raquel Duarte, Carla Nunes   +2 more
doaj   +1 more source